ADD3 and neoplasm: In sharp contrast to effective control in AdIL-17A-transduced tumors, both anti-Gr-1 and anti-G-CSF therapies only induced a modest reduction in tumor growth in Addl-transduced tumors and had little effect on lung metastasis (Fig. 9 and Supplementary Fig. 3).